118th Congress · SENATE BILLBILL

S. 1852 — Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

“A bill to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.”

Health

Introduced Jun 7, 2023

Last action Sep 6, 2023

Pipeline · Bill → Law

Step 1

Introduced

Jun 7, 2023

Step 2

Referred

Jun 7, 2023

HELP

Step 3

Committee

Jun 15, 2023

Reported out

Step 4

Senate

Sep 6, 2023

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Provisions · 2 sectionsReported to Senate

Timeline · 5 actions

Sep 6, 2023

Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.

Sep 6, 2023

Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.

Jun 15, 2023

Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.

Jun 7, 2023

Introduced in Senate

Jun 7, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.